Differences in cardiac but not in neuroendocrine responses in healthy volunteers after administration of two antimuscarinic agents, atropine and pirenzepine
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 39 (9) , 843-850
- https://doi.org/10.1016/0024-3205(86)90464-9
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Differential light microscopic autoradiographic localization of muscarinic cholinergic receptors in the brainstem and spinal cord of the rat using [3H]pirenzepineEuropean Journal of Pharmacology, 1983
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- Muscarinic receptor subclassesTrends in Pharmacological Sciences, 1983
- Effects of propantheline bromide on basal growth hormone, cortisol and prolactin levelsPsychoneuroendocrinology, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- Piperidine Enhances Sleep-Related and Insulin-Induced Growth Hormone Secretion: Further Evidence for a Cholinergic Secretory Mechanism*Journal of Clinical Endocrinology & Metabolism, 1981
- The character of the muscarinic receptors in different regions of the rat brainProceedings of the Royal Society of London. B. Biological Sciences, 1980
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- Neuropharmacological Regulation of Episodic Growth Hormone and Prolactin Secretion in the RatEndocrinology, 1978
- Cholinergic Blockade and Growth Hormone Responsiveness to Insulin HypoglycemiaExperimental Biology and Medicine, 1969